| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -56.62M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RAPP returned +226.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +59.0% |
| 1 year | +226.6% |
| All-time high | $48.24 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RAPP would be worth today ›No. Rapport Therapeutics, Inc. has not paid a dividend in the past 12 months.
Rapport Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol RAPP.
Rapport Therapeutics, Inc. is part of the Healthcare sector.
Rapport Therapeutics, Inc. has a market cap of 2.31B USD, based on the latest quote.
Rapport Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
